BBIO compared with LNTH: revenue, margins and what each company keeps, and the suppliers and customers both name

BBIOBridgeBio Pharma, Inc.

Mkt capRevenueRevenue

LNTHLantheus Holdings, Inc.

Mkt capRevenueRevenue

Compare

BBIOBridgeBio Pharma, Inc.

LNTHLantheus Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BBIO

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±10.2%▲+5.97%×0.59

Q2 FY26±6.9%▼−1.15%×0.16

May 8 '26±7.4%▼−0.09%×0.01

Q1 FY26±10.6%▼−2.59%×0.25

LNTH

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±4.6%▼−0.42%×0.09

May 7 '26±10.5%▲+5.63%×0.53

= impliedBBIO realized, solidLNTH realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.1%

▼−0.38%

×0.03

Nov 6 '25±18.5%▼−6.19%×0.34

BBIOBridgeBio Pharma, Inc.

75.33▲+0.50%

Mkt cap$14.6BRevenue$353MQ3 FY26Revenue$502MFY25

LNTHLantheus Holdings, Inc.

100.41▼−0.05%

Regular sessionNov 2 '26

Mkt cap$6.6BRevenue$388MQ2 FY26Revenue$1.5BFY24

Compare

Regular sessionNov 2 '26

BBIOBridgeBio Pharma, Inc.

LNTHLantheus Holdings, Inc.

75.33▲+0.50%

Price

100.41▼−0.05%

$14.6B

Mkt cap

$6.6B

Q3 FY26$353M

Revenue

$388MQ2 FY26

FY25$502M

Revenue

$1.5BFY24

BBIO75.33▲+0.50%vsLNTH100.41▼−0.05%Regular sessionNov 2 '26